 |
 Play Video: The Importance of Insider Buying
|
|
|
| Date | Insider | Price | Amount |
|---|
12-2-2016
Insider Buy |
Anthony J. Maddaluna
Director |
$16.46
CAGR »
|
$24,986.28
1,518 shares |
5-16-2016
Insider Buy |
William S. Marth
President and CEO |
$12.86
CAGR »
|
$160,750.00
12,500 shares |
5-13-2016
Insider Buy |
George Svokos
Chief Operating Officer |
$12.82
CAGR »
|
$160,250.00
12,500 shares |
6-4-2015
Insider Buy |
William S. Marth
President and CEO |
$19.98
CAGR »
|
$199,800.00
10,000 shares |
3-10-2015
Insider Buy |
George Svokos
Chief Commercial Officer |
$17.72
CAGR »
|
$177,200.00
10,000 shares |
3-5-2015
Insider Buy |
William S. Marth
President and CEO |
$17.70
CAGR »
|
$354,000.00
20,000 shares |
11-10-2014
Insider Buy |
William S. Marth
President and CEO |
$17.01
CAGR »
|
$510,300.00
30,000 shares |
5-15-2014
Insider Buy |
George Svokos
SVP Sales & GM of API |
$15.60
CAGR »
|
$156,000.00
10,000 shares |
5-12-2014
Insider Buy |
William S. Marth
President and CEO |
$15.40
CAGR »
|
$462,000.00
30,000 shares |
12-3-2013
Insider Buy |
William S. Marth
Director |
$10.75
CAGR »
|
$322,500.00
30,000 shares |
11-22-2013
Insider Buy |
William S. Marth
Director |
$11.57
CAGR »
|
$231,400.00
20,000 shares |
11-15-2012
Insider Buy |
Ambra Constance M. D
>10% Owner |
$3.80
CAGR »
|
$38,000.00
10,000 shares |
11-15-2012
Insider Buy |
Ambra Thomas E. Phd D
Chairman, CEO & President |
$3.80
CAGR »
|
$38,000.00
10,000 shares |
5-22-2012
Insider Buy |
Una S. Ryan
Director |
$2.81
CAGR »
|
$562.00
200 shares |
12-7-2011
Insider Buy |
Gabriel Leung
Director |
$2.40
CAGR »
|
$19,160.00
8,000 shares |
12-7-2011
Insider Buy |
Lori M. Henderson
VP, general counsel |
$2.47
CAGR »
|
$14,573.00
5,900 shares |
12-1-2011
Insider Buy |
Mark T. Frost
Chief Financial Officer |
$2.26
CAGR »
|
$22,600.00
10,000 shares |
Also See: Institutional Holders of AMRI
Also See: SEC filings
Below we present the annualized performance delivered by AMRI stock since 12-2-2016 (the date of the most recent
insider purchase). The performance of the investment from the time AMRI insider buying occurred is the ultimate
test of whether insiders were right about AMRI being a good buy.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
12/05/2016 |
|
| End date: |
08/31/2017 |
|
| Start price/share: |
$16.67 |
|
| End price/share: |
$21.74 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
30.41% |
|
| Annualized Gain: |
41.42% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$13,041.00 |
|
| Years: |
0.73 |
|
AMRI Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.),
and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these
categories, but instead file their holdings quarterly on the latest form 13F filings.
While recent AMRI insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding AMRI
|
|
Free AMRI Email Alerts:
